Perspective Therapeutics, Inc.·4

Apr 1, 5:03 PM ET

Graham Juan 4

4 · Perspective Therapeutics, Inc. · Filed Apr 1, 2025

Insider Transaction Report

Form 4
Period: 2025-03-28
Graham Juan
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-03-28$2.25/sh+33,333$74,94635,354 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.19 to $2.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4